Nicholas Keen, Chief Scientific Officer at BICYCLE THERAPEUTICS plc (BCYC), sold 6,910 shares at $45.00 ($311K) on 2021-09-15, disclosed to the SEC on 2021-09-17.
Open-market sale of $311k BCYC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 3,000 | $135K | 43.4% |
| 2 | $45.01 | 1,955 | $88K | 28.3% |
| 3 | $45.01 | 1,955 | $88K | 28.3% |
| Total | $45.01 avg | 6,910 | $311K | 100% |
| Filing → |
| BCYC | SELL | 2024-01-04 | $46K | — | Filing → |
| BCYC | SELL | 2023-10-05 | $5K | — | Filing → |
| BCYC | SELL | 2023-07-06 | $8K | — | Filing → |